A5014719341- Chronic Obstructive Pulmonary Disease (COPD) Research
- Asthma and respiratory diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- COVID-19 Clinical Research Studies
- Respiratory Support and Mechanisms
- vaccines and immunoinformatics approaches
- SARS-CoV-2 and COVID-19 Research
- Respiratory and Cough-Related Research
- Economic and Financial Impacts of Cancer
- Palliative Care and End-of-Life Issues
- Medical Imaging and Pathology Studies
- Atomic and Subatomic Physics Research
- Venous Thromboembolism Diagnosis and Management
- Intensive Care Unit Cognitive Disorders
- Cancer, Hypoxia, and Metabolism
- Pulmonary Hypertension Research and Treatments
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cardiac Arrest and Resuscitation
- Thermal Regulation in Medicine
- Non-Invasive Vital Sign Monitoring
- Hepatitis B Virus Studies
- Heart Rate Variability and Autonomic Control
- Global Cancer Incidence and Screening
Cambridge University Hospitals NHS Foundation Trust
2021-2024
University of Cambridge
2021-2024
East and North Hertfordshire NHS Trust
2021-2024
Lister Hospital
2024
Addenbrooke's Hospital
2021
The first case of novel SARS-COV-2 (COVID-19) in Pakistan was detected on 26 February 2020. Pharmacological and non-pharmacological strategies have been tried to lessen the mortality morbidity burden. Various vaccines approved. Drug Regulatory Authority gave emergency approval for Sinopharm (BBIBP-CorV) COVID-19 vaccine December 2021. phase 3 trial BBIBP-CorV included only 612 participants aged 60 years above. primary aim this study assess safety efficacy BBIBPP-CorV (Sinopharm) within...
Background/Aims Symptoms of malignancy are often vague and non-specific, leading to delayed diagnosis treatment. The multidisciplinary diagnostic centre was established in 2017 facilitate the shortest safest route detecting cancer such cases. This study aimed evaluate service model work towards a business case for more widespread adoption service. Methods Data from all patients managed by 2017–21 were collected contemporaneously. After 51 months, data examined against aims service, focusing...
Fluorine-fluorodeoxyglucose (
COVID-19 is a known risk factor for pulmonary embolism (PE). In this retrospective, multicenter study, we aimed to determine an optimal D-dimer cutoff predict PE in hospitalized patients with COVID-19.
Background Prone positioning has a beneficial role in coronavirus disease 2019 (COVID-19) patients receiving ventilation but lacks evidence awake non-ventilated patients, with most studies being retrospective, lacking control populations and information on subjective tolerability. Methods We conducted prospective, single-centre study of prone COVID-19 non-COVID-19 pneumonia. The primary outcome was change peripheral oxygenation versus supine position. Secondary outcomes assessed effects...
Background: The main aim of this study was to assess the efficacy advanced respiratory support (ARS) for acute failure in do-not-attempt cardiopulmonary resuscitation order (DNACPR) COVID-19 patients. Methods: In single-center study, impact different types ARS modality, PaO2/FiO2 (PF) ratio, clinical frailty score (CFS) and 4C on mortality evaluated. Results: There no significant difference age, type PF ratio scores between those who died survived. Overall survival rates/hospital discharge...
<b>Introduction:</b> Interstitial lung diseases (ILDs) are a heterogeneous group of progressive conditions. Tools to accurately prognosticate lacking. Positron Emission Tomography (PET) CT imaging offers non-invasive measure tissue metabolic activity and shows potential for use in ILD monitoring. The aim this study was investigate the relationship between baseline FDG-PET/CT signal quality life (QOL) at diagnosis longitudinally over 4 years determine utility PET-CT prognostication....
The first case of novel SARS-COV-2 (COVID-19) in Pakistan was detected on 26 February 2020. Pharmacological and non-pharmacological strategies have been tried to lessen the mortality morbidity burden. Various vaccines approved. Drug Regulatory Authority gave emergency approval for Sinopharm (BBIBP-CorV) COVID-19 vaccine December 2021. phase 3 trial BBIBP-CorV included only 612 participants aged 60 years above. primary aim this study assess safety efficacy BBIBPP-CorV (Sinopharm) within...
<h3>Introduction</h3> The impulse oscillometry system (IOS) provides an alternative method of lung function testing for patients in whom forced expiratory maneuvers are contraindicated, such as those with inherited vascular connective tissue disorders. Here we examine the role IOS diagnosis and monitoring asthma through a clinical case series literature review. <h3>Materials Methods</h3> comprised data from 12 disorders representing 32 encounters. Of these, 11 encounters were 21 monitoring....